Overview
Chambers USA 2021
Advances at each stage of the device and diagnostics development process, from initial creation to manufacturing, as well as consumer demand for patient-centric approaches to devices and diagnostic tools, have led large and small life sciences companies to seek collaborative partnerships that can efficiently and effectively address the needs of their varied stakeholders. When done correctly, these partnerships can have a transformational impact on your business and ensure that you remain competitive amid this rapidly evolving landscape.
All the factors to consider when creating these partnerships—pricing, reimbursement, technology requirements and patient needs—can be daunting when structuring a licensing agreement, strategic alliance or partnering transaction. It takes an experienced team that understands both the nuances of the life sciences space and the multidimensional aspects of a successful collaboration agreement to fulfill your organization’s mission while maintaining your competitive advantage.
McDermott’s life sciences lawyers leverage the combined power of collaboration and industry understanding to provide in-depth guidance to clients in every sector of the life sciences space, integrating the knowledge and experience of lawyers from across the Firm’s many Tier 1 practices to meet clients’ needs.
Our successful cross-border collaboration experience includes:
- Development of strategic structures
- Negotiation of complex arrangements
- Research and development agreements
- Joint venture formation and control
- Manufacturing and supply arrangements
- IP transfer and licensing
- Regulatory compliance
- Commercialization agreements
- Technology evaluation and option agreements
- Dispute resolution
- Academic and research institution agreements
Learn how McDermott can help you go further.
